Euromedis Groupe Past Earnings Performance

Past criteria checks 0/6

Euromedis Groupe's earnings have been declining at an average annual rate of -0.5%, while the Medical Equipment industry saw earnings declining at 9.5% annually. Revenues have been growing at an average rate of 1% per year.

Key information

-0.5%

Earnings growth rate

10.6%

EPS growth rate

Medical Equipment Industry Growth-9.5%
Revenue growth rate1.0%
Return on equity-17.0%
Net Margin-10.9%
Last Earnings Update31 Dec 2022

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown
Beta

How Euromedis Groupe makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

LSE:0I0L Revenue, expenses and earnings (EUR Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
31 Dec 2254-6250
30 Sep 2262-7260
30 Jun 2269-8260
31 Mar 2291-3270
31 Dec 211122270
30 Sep 2115813280
30 Jun 2120423290
31 Mar 2119923290
31 Dec 2019323280
30 Sep 2014712280
30 Jun 201000270
31 Mar 2089-2270
31 Dec 1977-4280
31 Dec 1876-5260
31 Jan 1876-1320
31 Oct 1775-1290
31 Jul 17740250
30 Apr 17741180
31 Jan 17741110
31 Oct 16741120
31 Jul 16741120
30 Apr 16732120
31 Jan 16722120
31 Oct 15722120
31 Jul 15722110
30 Apr 15712110
31 Jan 15712110
31 Oct 14722110
31 Jul 14723110
30 Apr 14743110
31 Jan 14752110
31 Oct 13762110
31 Jul 13762110
30 Apr 13762110
31 Jan 13761110
31 Oct 12761110

Quality Earnings: 0I0L is currently unprofitable.

Growing Profit Margin: 0I0L is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: 0I0L is unprofitable, and losses have increased over the past 5 years at a rate of 0.5% per year.

Accelerating Growth: Unable to compare 0I0L's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: 0I0L is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (-12.2%).


Return on Equity

High ROE: 0I0L has a negative Return on Equity (-17.03%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.